IMMUNE CHECKPOINT INHIBITORS – 3RD TYPE OF IMMUNOTHERAPY

IMMUNE CHECKPOINT INHIBITORS – 3RD TYPE OF IMMUNOTHERAPY Immune checkpoint inhibitors are a third type of immunotherapy (for other types search in the news ⬇️) Immune checkpoints on cell surfaces help control an immune response. Usually, immune checkpoints keep T cells inactive, that is, in an off state, until they’re needed. This keeps the T […]

T CELL DYNAMICS WITH NEOADJUVANT IMMUNOTHERAPY IN HEAD AND NECK CANCER

T CELL DYNAMICS WITH NEOADJUVANT IMMUNOTHERAPY IN HEAD AND NECK CANCER Neoadjuvant immune-checkpoint inhibitors (ICIs) have been shown to be safe with promising early trial results in patients with locally advanced, resectable human papillomavirus-unrelated head and neck squamous cell carcinoma. Immune-checkpoint inhibitors (ICIs) are being tested as neoadjuvant therapies in various solid tumours, including in […]